https://www.marketscreener.com/quote/stock/ADDEX-THERAPEUTICS-LTD-261774/news/Press-Release-Addex-Therapeutics-Initiates-Pivotal-Phase-2b-3-Study-with-Dipraglurant-for-Dyskines-35737980/?utm_source=telegram&utm_medium=social&utm_campaign=share